Page last updated: 2024-10-25

chlorpropamide and Movement Disorders

chlorpropamide has been researched along with Movement Disorders in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
VERCESI, G1
GATTI, E1

Other Studies

1 other study available for chlorpropamide and Movement Disorders

ArticleYear
[PROLONGED HYPOGLYCEMIC COMA AND IRREVERSIBLE CEREBRAL CAUSED BY ADMINISTRATION OF CHLORPROPAMIDE IN A NON-DIABETIC PATIENT].
    L' Ospedale maggiore, 1963, Volume: 58

    Topics: Brain; Brain Damage, Chronic; Brain Injuries; Cerebral Ventriculography; Chlorpropamide; Coma; Diabe

1963